Skip to main content

GSA CAPITAL PARTNERS LLP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1362033 LONDON, X0

Position in BCRX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$902,100
+$57,914 QoQ
Shares Held
90,210
-16.6% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#128
of 316 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (7.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 BCRX
Biocryst Pharmaceuticals Inc
This page
90,210 $902,100

All Filings in BCRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $902,100 90,210
2025-12-31 $844,186 108,229
2025-09-30 $1,444,331 190,294
2025-06-30 $998,744 111,467
2025-03-31 $2,089,140 278,552
2024-12-31 $1,236,919 164,484
2024-09-30 $2,170,468 285,588
2024-06-30 $2,248,518 363,838
2023-12-31 $1,070,826 178,769
2023-09-30 $1,356,011 191,527
2023-06-30 $503,585 71,532
2023-03-31 $1,282,008 153,718
2022-09-30 $240,924 19,121
2021-09-30 $590,836 41,116
2021-03-31 $815,603 80,197
2020-12-31 $78,225 10,500
2020-06-30 $188,491 39,599
2020-03-31 $277,328 138,664